“Clover is well positioned to make a significant impact on the COVID-19 response with our premium and broadly protective protein-based vaccine, both in China and globally, where the need to boost protection will likely provide attractive and unique opportunities f...
production, and commercialization of innovative vaccines for global public health security. It possesses five integrated platform technologies including viral vector-based technology, synthetic vaccine technology, protein structure design and recombinant VLP technology, mRNA vaccine technology as well...
The terms of the agreement include: a co-exclusive license to co-commercialize Novavax’s current stand-alone adjuvanted COVID-19 vaccine worldwide (except in countries with existing Advance Purchase Agreements and in Indi...
Influenza vaccine coverage also was low but far outpaced COVID-19 vaccine uptake. There was a “marked decrease” in COVID-19 vaccine uptake among nursing home personnel last season, according to researchers, who attributed the decline to cost and the end of the CMS’s COVID-19 vacc...
COVID-19 Mitigation Products (PPE, Serologic Test, Contact Tracing, COVID-19 Drugs, COVID-19 Vaccine, Polymerase Chain Reaction, PCR Test Kits, Blockchain Technologies, Surge Hospitals, Self-collection Swabs, AI, Personal Protection Gear, Teleradiology, Eye Protection, Ultrasound, Dialysis, CT, ...
FRANKFURT, March 16 (Xinhua) -- German pharmaceutical company BioNTech on Monday announced its strategic alliance with the pharmaceutical arm of China's Fosun Group for the development and commercialization of the COVID-19 vaccine in China.
COVID-19 Vaccine and Therapeutics Tracker, updated daily. Get the latest updates on vaccine and therapeutic drug development for coronavirus.
one in every 1,300 people alive in 2019 has died from infection with SARS-CoV-2. Two years on, it is easy to forget how remarkable the development of COVID-19 vaccines was: moving in just 326 days from a genomic sequence to the authorization of a vaccine shattered all previous records...
PharmaJet’s mission is to improve people’s lives through needle-free technology. PharmaJet Needle-free Systems provide increased vaccine effectiveness, a preferred patient and caregiver experience, and a proven path to commercialization. They are also safe, fast, and easy-to...
(CMA) for Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. The authorization follows the European Medicines Agency's (EMA) Committee for Medicinal Products for...